1. Home
  2. NRXP vs FGL Comparison

NRXP vs FGL Comparison

Compare NRXP & FGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • FGL
  • Stock Information
  • Founded
  • NRXP 2015
  • FGL 2021
  • Country
  • NRXP United States
  • FGL Malaysia
  • Employees
  • NRXP N/A
  • FGL N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • FGL
  • Sector
  • NRXP Health Care
  • FGL
  • Exchange
  • NRXP Nasdaq
  • FGL NYSE
  • Market Cap
  • NRXP 32.6M
  • FGL 25.4M
  • IPO Year
  • NRXP N/A
  • FGL 2024
  • Fundamental
  • Price
  • NRXP $3.24
  • FGL $0.88
  • Analyst Decision
  • NRXP Strong Buy
  • FGL
  • Analyst Count
  • NRXP 4
  • FGL 0
  • Target Price
  • NRXP $28.50
  • FGL N/A
  • AVG Volume (30 Days)
  • NRXP 212.8K
  • FGL 1.3M
  • Earning Date
  • NRXP 08-13-2025
  • FGL 07-22-2025
  • Dividend Yield
  • NRXP N/A
  • FGL N/A
  • EPS Growth
  • NRXP N/A
  • FGL N/A
  • EPS
  • NRXP N/A
  • FGL N/A
  • Revenue
  • NRXP N/A
  • FGL $20,205,441.00
  • Revenue This Year
  • NRXP N/A
  • FGL N/A
  • Revenue Next Year
  • NRXP N/A
  • FGL N/A
  • P/E Ratio
  • NRXP N/A
  • FGL N/A
  • Revenue Growth
  • NRXP N/A
  • FGL N/A
  • 52 Week Low
  • NRXP $1.10
  • FGL $0.66
  • 52 Week High
  • NRXP $6.01
  • FGL $5.26
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 53.62
  • FGL N/A
  • Support Level
  • NRXP $2.90
  • FGL N/A
  • Resistance Level
  • NRXP $3.53
  • FGL N/A
  • Average True Range (ATR)
  • NRXP 0.20
  • FGL 0.00
  • MACD
  • NRXP -0.04
  • FGL 0.00
  • Stochastic Oscillator
  • NRXP 58.73
  • FGL 0.00

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About FGL FOUNDER GROUP LTD

Founder Group Ltd is a solar solutions provider in Malaysia, offering end-to-end services for commercial and industrial sectors, as well as large-scale solar power projects, encompassing project design, engineering, and comprehensive project management. Its focus is on two key segments: large-scale solar projects and commercial and industrial (C&I) solar projects. Large-scale solar projects are utility scale solar PV power plants with installed generating capacity of 1 MWac or more. C&I projects are smaller scale solar projects where the solar PV systems are installed on rooftops and are designed to generate electricity for commercial and industrial properties for their own consumption, such as factories, warehouses and commercial stores. Its revenue is derived from Malaysia.

Share on Social Networks: